Your browser doesn't support javascript.
loading
Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis.
Oomen, Priscilla P; Begemann, Marieke J H; Brand, Bodyl A; de Haan, Lieuwe; Veling, Wim; Koops, Sanne; van Os, Jim; Smit, Filip; Bakker, P Roberto; van Beveren, Nico; Boonstra, Nynke; Gülöksüz, Sinan; Kikkert, Martijn; Lokkerbol, Joran; Marcelis, Machteld; Rosema, Bram-Sieben; de Beer, Franciska; Gangadin, Shiral S; Geraets, Chris N W; van 't Hag, Erna; Haveman, Yudith; van der Heijden, Inge; Voppel, Alban E; Willemse, Elske; van Amelsvoort, Therese; Bak, Maarten; Batalla, Albert; Been, Agaath; van den Bosch, Marinte; van den Brink, Truus; Faber, Gunnar; Grootens, Koen P; de Jonge, Martin; Knegtering, Rikus; Kurkamp, Jörg; Mahabir, Amrita; Pijnenborg, Gerdina H M; Staring, Tonnie; Veen, Natalie; Veerman, Selene; Wiersma, Sybren; Graveland, Ellen; Hoornaar, Joelle; Sommer, Iris E C.
Afiliación
  • Oomen PP; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Begemann MJH; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Brand BA; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • de Haan L; Department of Early Psychosis, Amsterdam UMC, Academic Medical Center, Amsterdam, The Netherlands.
  • Veling W; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Koops S; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • van Os J; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Smit F; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MheNS), Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Bakker PR; King's College London, King's Health Partners Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • van Beveren N; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.
  • Boonstra N; Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, The Netherlands.
  • Gülöksüz S; Centre of Economic Evaluation & Machine Learning, Trimbos Institute (Netherlands Institute of Mental Health), Utrecht, The Netherlands.
  • Kikkert M; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MheNS), Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Lokkerbol J; Department of Research, Arkin Mental Health Care, Amsterdam, The Netherlands.
  • Marcelis M; Antes Center for Mental Health Care, Rotterdam, The Netherlands.
  • Rosema BS; Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
  • de Beer F; Department of Psychiatry, Erasmus MC, Rotterdam, The Netherlands.
  • Gangadin SS; NHL/Stenden, University of Applied Sciences, Leeuwarden, The Netherlands.
  • Geraets CNW; KieN VIP Mental Health Care Services, Leeuwarden, The Netherlands.
  • van 't Hag E; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MheNS), Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Haveman Y; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
  • van der Heijden I; Department of Research, Arkin Mental Health Care, Amsterdam, The Netherlands.
  • Voppel AE; Centre of Economic Evaluation & Machine Learning, Trimbos Institute (Netherlands Institute of Mental Health), Utrecht, The Netherlands.
  • Willemse E; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, EURON, Maastricht University Medical Center, Maastricht, The Netherlands.
  • van Amelsvoort T; Institute for Mental Health Care Eindhoven (GGzE), Eindhoven, The Netherlands.
  • Bak M; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Batalla A; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Been A; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • van den Bosch M; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • van den Brink T; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Faber G; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Grootens KP; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • de Jonge M; Janssen-Cilag B.V., Breda, the Netherlands.
  • Knegtering R; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Kurkamp J; Department of Biomedical Sciences of Cells and Systems, and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Mahabir A; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MheNS), Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Pijnenborg GHM; Mondriaan Mental Health Care, Heerlen, The Netherlands.
  • Staring T; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MheNS), Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Veen N; Mondriaan Mental Health Care, Heerlen, The Netherlands.
  • Veerman S; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Wiersma S; Dimence Institute for Mental Health, Deventer, Zwolle, The Netherlands.
  • Graveland E; Dimence Institute for Mental Health, Deventer, Zwolle, The Netherlands.
  • Hoornaar J; Early Intervention Team, GGZ Centraal, Amersfoort, The Netherlands.
  • Sommer IEC; Yulius, Mental Health Institute, Dordrecht, The Netherlands.
Psychol Med ; 53(6): 2317-2327, 2023 04.
Article en En | MEDLINE | ID: mdl-34664546
ABSTRACT

BACKGROUND:

Cognitive deficits may be characteristic for only a subgroup of first-episode psychosis (FEP) and the link with clinical and functional outcomes is less profound than previously thought. This study aimed to identify cognitive subgroups in a large sample of FEP using a clustering approach with healthy controls as a reference group, subsequently linking cognitive subgroups to clinical and functional outcomes.

METHODS:

204 FEP patients were included. Hierarchical cluster analysis was performed using baseline brief assessment of cognition in schizophrenia (BACS). Cognitive subgroups were compared to 40 controls and linked to longitudinal clinical and functional outcomes (PANSS, GAF, self-reported WHODAS 2.0) up to 12-month follow-up.

RESULTS:

Three distinct cognitive clusters emerged relative to controls, we found one cluster with preserved cognition (n = 76), one moderately impaired cluster (n = 74) and one severely impaired cluster (n = 54). Patients with severely impaired cognition had more severe clinical symptoms at baseline, 6- and 12-month follow-up as compared to patients with preserved cognition. General functioning (GAF) in the severely impaired cluster was significantly lower than in those with preserved cognition at baseline and showed trend-level effects at 6- and 12-month follow-up. No significant differences in self-reported functional outcome (WHODAS 2.0) were present.

CONCLUSIONS:

Current results demonstrate the existence of three distinct cognitive subgroups, corresponding with clinical outcome at baseline, 6- and 12-month follow-up. Importantly, the cognitively preserved subgroup was larger than the severely impaired group. Early identification of discrete cognitive profiles can offer valuable information about the clinical outcome but may not be relevant in predicting self-reported functional outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Disfunción Cognitiva Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Psychol Med Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Disfunción Cognitiva Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Psychol Med Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos